Table 2.
Sample | Early infectiona | Mid infectiona | Late infectiona |
---|---|---|---|
Serumc | 0.894 ± 0.550 | 27.32 ± 18.18 | 1973±1725 |
Infected eard | 16.25 ± 14.32 | 94.25 ± 63.05 | 1201 ± 207.4 |
Control eard | 0.099 ± 0.054 | 0.569 ± 0.336 | 28.75 ± 14.28 |
Infected lymph noded | 0.253 ± 0.253 | 547.5 ± 183.6 | 5057 ± 2889 |
Control lymph noded | < LODb | 2.626 ± 1.816 | 868.4 ± 575.3 |
Heartd | 0.043 ± 0.043 | 16.70 ± 15.23 | 382.3 ± 343.7 |
Lungsd | 0.044 ± 0.032 | 5.865 ± 5.160 | 601.1 ± 497.6 |
Spleend | 0.041 ± 0.041 | 2.606 ± 1.717 | 1115 ± 895.9 |
Liverd | 0.008 ± 0.004 | 9.057 ± 8.622 | 895.7 ± 611.0 |
Right bone marrowc | < LODb | 0.145 ± 0.100 | 27.68 ± 24.42 |
Left bone marrowc | < LODb | 0.132 ± 0.088 | 22.27 ± 17.10 |
Braind | < LODb | 0.092 ± 0.066 | 60.25 ± 41.73 |
Injection of 1 × 105 spores of luminescent 7702 (BIG23) spores subcutaneously into the left ear of three A/J mice. Samples were collected and processed when mice reached the indicated stage of infection.
Samples where potential LF concentrations are below the limit of detection (LOD).
Samples reported in ng ml−1 ± standard error of the mean.
Samples reported in ng g−1 of tissue standard ± error of the mean.